AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research

被引：0
|
作者：
Lei-Lei Wu
Wen-Mei Jiang
Zhi-Yuan Liu
Yi-Yi Zhang
Jia-Yi Qian
Yu’e Liu
Yang-Yu Huang
Kun Li
Zhi-Xin Li
Guo-Wei Ma
Dong Xie
机构：
[1] Tongji University,Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine
[2] Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
[3] Tongji University,School of Medicine
[4] The University of Manchester,Faculty of Biology, Medicine and Health, School of Biological Sciences
来源：
Discover Oncology | / 14卷
关键词：
KRAS G12C mutation; AMG-510; Cisplatin; In vivo; Translational medicine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Arnold Lee
    Targeted Oncology, 2022, 17 : 727 - 733
  • [32] Validated HPLC-MS/MS method for quantitation of AMG 510, a KRAS G12C inhibitor, in mouse plasma and its application to a pharmacokinetic study in mice
    Madhyastha, Naveena
    Samantha, Swapan Kumar
    Dittakavi, Sreekanth
    Markose, Meenu
    Mallurwar, Sadanand Rangnathrao
    Zainuddin, Mohd
    Mullangi, Ramesh
    BIOMEDICAL CHROMATOGRAPHY, 2021, 35 (04)
  • [33] KRAS-G12C Mutation Is Associated with Poor Outcome in Surgically Resected Lung Adenocarcinoma
    Nadal, Ernest
    Chen, Guoan
    Prensner, John R.
    Shiratsuchi, Hiroe
    Sam, Christine
    Zhao, Lili
    Kalemkerian, Gregory P.
    Brenner, Dean
    Lin, Jules
    Reddy, Rishindra M.
    Chang, Andrew C.
    Capella, Gabriel
    Cardenal, Felipe
    Beer, David G.
    Ramnath, Nithya
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (10) : 1513 - 1522
  • [34] Synergistic antitumor activity of nab-sirolimus in combination with KRAS inhibitors (KRASis) sotorasib and adagrasib in KRAS G12C NSCLC and bladder cancer xenografts
    Hou, Shihe
    Kwon, Andrew
    Nieva, Jorge
    Desai, Neil
    CANCER RESEARCH, 2023, 83 (07)
  • [35] The histopathological spectrum and molecular changes associated with KRAS G12C mutation in non-small cell lung carcinoma
    Li, Jing Jing
    Wu, Xiao Juan
    Farzin, Mahtab
    Bray, Victoria
    Williamson, Jonathan
    Pal, Abhiji
    Yip, Po Yee
    Hagelamin, Abeer
    Ding, Pei
    Nindra, Udit
    Vinod, Shalini
    French, Bruce
    Chua, Wei
    Gupta, Ruta
    Cooper, Wendy A.
    Wang, Bin
    Lee, C. Soon
    PATHOLOGY, 2024, 56 (06) : 786 - 794
  • [36] Correction to: Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Arnold Lee
    Targeted Oncology, 2023, 18 : 177 - 177
  • [37] Selinexor (XPO1 inhibitor) in combination with tepotinib (MET inhibitor) potentially inhibits SHOC2 and KRAS G12C in KRAS G12C mutant non-small cell lung cancer
    Rosell, R.
    Jain, A.
    Codony-Servat, J.
    Shivamallu, C.
    Kollur, S. P.
    Prasad, A.
    Vishwanath, P.
    Jantus Lewintre, E.
    Ito, M.
    Cardona Zorrilla, A. F.
    Arrieta Rodriguez, O. G.
    Pedraz-Valdunciel, C.
    Gonzalez Nieto, J.
    Aguilar, A.
    Molina-Vila, M. A.
    Gonzalez Cao, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1188 - S1188
  • [38] Targeting KRAS-Mutant Non-Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on KRAS G12C Mutations
    Burns, Timothy F.
    Borghaei, Hossein
    Ramalingam, Suresh S.
    Mok, Tony S.
    Peters, Solange
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (35) : 4208 - 4218
  • [39] Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V Mutation
    Chaft, Jamie E.
    Litvak, Anya
    Arcila, Maria E.
    Patel, Payal
    D'Angelo, Sandra P.
    Krug, Lee M.
    Rusch, Valerie
    Mattson, Alicia
    Coeshott, Claire
    Park, Bernard
    Apelian, David M.
    Kris, Mark G.
    Azzoli, Christopher G.
    CLINICAL LUNG CANCER, 2014, 15 (06) : 405 - 410
  • [40] KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer
    Park, Sehhoon
    Kim, Ji-Yeon
    Lee, Se-Hoon
    Suh, Beomseok
    Keam, Bhumsuk
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 514 - 522
12345